ABBV · 10-Q · 2026Q2 · Full report

Balance Sheet and Liquidity

AbbVie Inc. · 2026-08-03 · Importance 33 · Surprise 24

AbbVie maintained $8.0 billion of available unsecured revolving credit facilities at June 30, 2026, consisting of facilities maturing in March 2028 and January 2030. No amounts were outstanding under either revolving facility at June 30, 2026 or December 31, 2025. The company was in compliance with all revolving-facility covenants at June 30, 2026. Moody’s upgraded AbbVie’s senior unsecured rating to A2 and short-term rating to Prime-1 in February 2026, while S&P affirmed its A- rating and raised its outlook to positive in June 2026.

Key facts

• There were no commercial paper borrowings outstanding as of June 30, 2026; commercial paper borrowings outstanding totaled $499 million as of December 31, 2025. source